Study at a glance
What question did the studies ask?
Researchers asked how vitamin D affects cells with features of senescence. Senescence is a state in which cells stop dividing for a long time but remain active. This review compares laboratory experiments and one small randomized human trial.
What did the researchers find?
Most laboratory studies used calcitriol, the active vitamin D hormone. Some experiments found changes in proteins involved in DNA repair. DNA is the material that carries genetic information. Others found lower release of selected inflammatory substances. Another improved a response to introduced DNA. These changes did not establish that the cells began dividing again or were removed. Other experiments found more senescence-associated features in injured human lung-cancer cells and kidney-cancer cells. Those models differ from healthy human tissue.
The human trial studied 88 older adults with low vitamin D levels. It compared two daily vitamin D3 doses, with or without N-acetylcysteine, for eight weeks. Higher-dose groups had lower selected blood-cell measurements than the lower dose alone. Some other measurements did not show a clear difference between groups. Blood inflammation measures did not show clear differences between groups. A staining result was not a direct count of senescent cells.
What does this mean?
Vitamin D can affect particular cell processes without establishing reversal of senescence. Laboratory hormone treatment, receptor deletion and oral vitamin D3 are different interventions. These studies did not establish that vitamin D clears senescent cells or slows ageing in people.
Read the full article below ↓Vitamin D can affect particular processes in cells with senescence-associated features. Senescence involves cells stopping division for a long time while remaining active. DNA carries genetic information. Changes in its repair, inflammatory substances or cell measurements do not by themselves show that the cells were removed or began dividing again. For the detailed evidence, read Vitamin D and Cellular Senescence Pathways: Full Evidence Review.
What was studied?
The review compares laboratory experiments and a small randomized human trial. Different models used repeated cell growth, an activated cancer-related gene, exposure to radiation, chemical injury or malignant cells. These are different settings. Most cell experiments used calcitriol, the active vitamin D hormone. The human trial used oral vitamin D3. Vitamin D and Cellular Senescence introduces the wider cell biology.
What did the laboratory studies find?
Cells grown from human bone marrow grew more slowly with calcitriol and retained the ability to develop along several specialised routes. Some ageing-associated measurements changed, but the overall number of times the cells divided did not show a clear treatment difference. This did not establish an increase in how many times the cells could divide or a return to younger tissue function. The distinction from differentiation is explained in Vitamin D and Cell Differentiation. [1]
In fibroblasts, a type of connective-tissue cell, with an activated cancer-related gene, calcitriol restored selected DNA-repair proteins without preventing the senescent growth arrest. In skin fibroblasts already made senescent by irradiation, it lowered release of selected inflammatory substances. Lower secretion did not demonstrate cell removal or resumed division. [2] [3]
Other results pointed in a different direction. Calcitriol increased selected senescence-associated features in injured lung-cancer-derived cells and in a kidney-cancer cell model. Those findings cannot be transferred directly to healthy ageing tissues. Oxidative injury is one context discussed in Vitamin D and Oxidative Stress. [4] [5]
Another fibroblast study improved selected responses to introduced DNA. A separate lifespan result in that paper came from a different drug, not vitamin D. A skeletal study linked receptor signalling with cell-cycle regulation, but genetic deletion of a cell-cycle regulator was not vitamin D treatment or removal of senescent cells. [6] [7]
What did the human trial find?
Eighty-eight older adults with low vitamin D levels received 1,000 or 5,000 international units of vitamin D3 daily, with or without a separate substance called N-acetylcysteine, for eight weeks. Every group received vitamin D3; there was no placebo or N-acetylcysteine-only group. A correction confirms the higher dose was 5,000 units, not erroneous 50,000-unit table labels. These are research regimens, not personal dose recommendations. [8] [9]
The higher-dose groups had lower activity of selected genes and a lower staining measurement than the lower dose alone. The staining was green-pixel area, not a direct percentage of senescent cells. Other measurements did not show clear between-group differences, including activity of the gene called p21 and blood inflammation measures. The trial did not establish cell clearance or better resistance to infection or recovery from illness. [8]
How should the findings be interpreted?
Preventing senescence, reversing growth arrest, removing senescent cells and changing their secretions are separate claims. The experiments support changes in selected processes, with different responses across models. They do not establish that vitamin D reverses cell ageing or slows ageing in people. The broader tissue question belongs within Vitamin D and Age-Related Decline.
Scientific sources
[1] 1,25-dihydroxyvitamin D3 treatment delays cellular aging in human mesenchymal stem cells while maintaining their multipotent capacity. Klotz B, Mentrup B, Regensburger M, Zeck S, Schneidereit J, Schupp N, Linden C, Merz C, Ebert R, Jakob F. PloS one. 2012;7(1):e29959. DOI 10.1371/journal.pone.0029959; PMID 22242193; PMCID PMC3252365.
[2] Vitamin D/vitamin D receptor axis regulates DNA repair during oncogene-induced senescence. Graziano S, Johnston R, Deng O, Zhang J, Gonzalo S. Oncogene. 2016;35(41):5362-5376. DOI 10.1038/onc.2016.77; PMID 27041576; PMCID PMC5050051.
[3] Vitamin D3 inhibits p38 MAPK and senescence-associated inflammatory mediator secretion by senescent fibroblasts that impacts immune responses during ageing. Sayegh S, Fantecelle CH, Laphanuwat P, Subramanian P, Rustin MHA, Gomes DCO, Akbar AN, Chambers ES. Aging cell. 2024;23(4):e14093. DOI 10.1111/acel.14093; PMID 38287646; PMCID PMC11019144.
[4] Detrimental pro-senescence effects of vitamin D on lung fibrosis. Guijarro T, Magro-Lopez E, Manso J, Garcia-Martinez R, Fernandez-Aceñero MJ, Liste I, Zambrano A. Molecular medicine (Cambridge, Mass.). 2018;24(1):64. DOI 10.1186/s10020-018-0064-z; PMID 30567504; PMCID PMC6299997.
[5] Calcitriol induces cell senescence of kidney cancer through JMJD3 mediated histone demethylation. Shen Y, Yu D, Qi P, Wang X, Guo X, Zhang A. Oncotarget. 2017;8(59):100187-100195. DOI 10.18632/oncotarget.22124; PMID 29245970; PMCID PMC5725012.
[6] A noncanonical cGAS-STING pathway drives cellular and organismal aging. Cancado de Faria R, Silva LND, Teodoro-Castro B, McCommis KS, Shashkova EV, Gonzalo S. Proceedings of the National Academy of Sciences of the United States of America. 2025;122(28):e2424666122. DOI 10.1073/pnas.2424666122; PMID 40638086; PMCID PMC12280946.
[7] Active vitamin D protects against osteoporosis by promoting VDR-dependent CDK2 transcription and P27 degradation. Xu F, Liu Q, Huang M, Wang J, Goltzman D, Gu B, Miao D. European journal of endocrinology. 2026;195(2):329-344. DOI 10.1093/ejendo/lvag152; PMID 42592858.
[8] Co-administration of vitamin D and N-acetylcysteine to modulate immunosenescence in older adults with vitamin D deficiency: a randomized clinical trial. Rastgoo S, Pourvali K, Raeissadat SA, Eslamian G, Zand H. Frontiers in immunology. 2025;16:1570441. DOI 10.3389/fimmu.2025.1570441; PMID 40421021; PMCID PMC12104082.
[9] Corrigendum: Co-administration of vitamin D and N-acetylcysteine to modulate immunosenescence in older adults with vitamin D deficiency: a randomized clinical trial Rastgoo S, Pourvali K, Raeissadat SA, Eslamian G, Zand H. Frontiers in Immunology. 2025;16:1627178. DOI 10.3389/fimmu.2025.1627178; PMID 40510343.
Related reading
1,25-Dihydroxyvitamin D3 Treatment Delays Cellular Aging in Human Mesenchymal Stem Cells while Maintaining Their Multipotent Capacity
We wanted to know if 1,25D3 is able to modulate aging processes on a cellular level in human mesenchymal stem cells (hMSC).
Original paper ↗Read more →Calcitriol induces cell senescence of kidney cancer through JMJD3 mediated histone demethylation
In this study, the biological effect and epigenetic regulation of calcitriol on kidney cancer cells were investigated.
Original paper ↗Read more →Detrimental pro-senescence effects of vitamin D on lung fibrosis
The multiple biological effects of vitamin D and its novel activities on inflammation and redox homeostasis have raised high expectations on its use as a therapeutic agent for multiple fibrogenic conditions.
Original paper ↗Read more →Vitamin D3 inhibits p38 MAPK and senescence‐associated inflammatory mediator secretion by senescent fibroblasts that impacts immune responses during ageing
Vitamin D3 replacement in older insufficient adults significantly improves their antigen‐specific varicella zoster virus (VZV) cutaneous immunity.
Original paper ↗Read more →Vitamin D and Cellular Senescence Pathways: Full Evidence Review
Evidence on vitamin D and cell ageing pathways: growth arrest, DNA repair, inflammatory secretions and opposing responses in different experimental models.
Read more →Vitamin D, Cellular Senescence and Chronic Kidney Diseases: What Is Missing in the Equation?
As life expectancy increases in many countries, the prevalence of age-related diseases also rises.
Original paper ↗Read more →Modulation of renal inflammation and tubular injury by calcitriol in patients with early diabetic kidney disease: a randomized controlled trial
This double-blind, randomized controlled trial investigated the effects of calcitriol supplementation on kidney injury biomarkers in patients with early DKD.
Original paper ↗Read more →Epidemiology of 40 blood biomarkers of one-carbon metabolism, vitamin status, inflammation, and renal and endothelial function among cancer-free older adults
Imbalances of blood biomarkers are associated with disease, and biomarkers may also vary non-pathologically across population groups.
Original paper ↗Read more →Vitamin D and Cellular Senescence
Explains the relationship between vitamin D and cellular senescence, including gene regulation, mitochondrial function, oxidative stress, and inflammatory signalling, and how these processes relate to ageing cells.
Read more →1,25-Dihydroxyvitamin D Deficiency Accelerates Aging-related Osteoarthritis via Downregulation of Sirt1 in Mice
Emerging observational data suggest that vitamin D deficiency is associated with the onset and progression of knee osteoarthritis (OA).
Original paper ↗Read more →Calcitriol-mediated hypercalcemia as an immune-related adverse event in a patient receiving nivolumab and ipilimumab for metastatic renal cell carcinoma, case report
Severe hypercalcemia is often associated with uncontrolled malignancy through several mechanisms.
Original paper ↗Read more →Effect of Paricalcitol vs Calcitriol on Hemoglobin Levels in Chronic Kidney Disease Patients: A Randomized Trial
Therefore, we conducted a study to determine whether paricalcitol, compared to calcitriol, improves anemia in patients with chronic kidney disease (CKD).
Original paper ↗Read more →Low-dose oral cholecalciferol is associated with higher numbers of Helios+ and total Tregs than oral calcitriol in renal allograft recipients: an observational study
We evaluated whether there was a difference in the absolute numbers of Helios+, Helios−, CTLA-4+, IFNg+, and total Tregs among the patient groups.
Original paper ↗Read more →The impact of a needs-oriented dental prophylaxis program on bacteremia after toothbrushing and systemic inflammation in children, adolescents, and young adults with chronic kidney disease
General prevalence of bacteremia after toothbrushing was 9.5% affecting 7 (26%) of the participants.
Original paper ↗Read more →Calcitriol enhances Doxorubicin‐induced apoptosis in papillary thyroid carcinoma cells via regulating VDR/PTPN2/p‐STAT3 pathway
The primary aim of this study was to investigate the role of Calcitriol on papillary thyroid carcinoma (PTC) and explore the possible mechanism.
Original paper ↗Read more →Dietary-Induced Bacterial Metabolites Reduce Inflammation and Inflammation-Associated Cancer via Vitamin D Pathway
Environmental factors, including westernised diets and alterations to the gut microbiota, are considered risk factors for inflammatory bowel diseases (IBD).
Original paper ↗Read more →Calcitriol Supplementation Causes Decreases in Tumorigenic Proteins and Different Proteomic and Metabolomic Signatures in Right versus Left-Sided Colon Cancer
Vitamin D deficiency is a common problem worldwide.
Original paper ↗Read more →Effects of personalized vitamin D3 on inflammation in colorectal cancer patients: a randomized trial
In an ongoing randomized double-blind, placebo-controlled trial in Germany, CRC patients who underwent surgery in the past year and had serum 25-hydroxyvitamin D levels.
Original paper ↗Read more →H3K4me3 Is a Potential Mediator for Antiproliferative Effects of Calcitriol (1α,25(OH)2D3) in Ovarian Cancer Biology
Our study evaluated the expression level of histone 3 lysine 4 trimethylation (H3K4me3) in a cohort of 156 epithelial ovarian cancer (EOC) cases by immunohistochemical staining and analyzed its correlation to patient prognosis.
Original paper ↗Read more →Mechanistic Effects of Calcitriol in Cancer Biology
In the context of cancer, calcitriol regulates the cell cycle, induces apoptosis, promotes cell differentiation and acts as anti-inflammatory factor within the tumor microenvironment.
Original paper ↗Read more →Plasma 25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D Levels in Breast Cancer Risk in Mali: A Case-Control Study
The aim of the current study was to determine the association between metabolites circulating in the blood, 25(OH)D and 1,25(OH)2D, and vitamin D levels with the risk of breast cancer in Malian women.
Original paper ↗Read more →Original sources
1,25-Dihydroxyvitamin D3 Treatment Delays Cellular Aging in Human Mesenchymal Stem Cells while Maintaining Their Multipotent Capacity
We wanted to know if 1,25D3 is able to modulate aging processes on a cellular level in human mesenchymal stem cells (hMSC).
Publication details
[1] 1,25-dihydroxyvitamin D3 treatment delays cellular aging in human mesenchymal stem cells while maintaining their multipotent capacity. Klotz B, Mentrup B, Regensburger M, Zeck S, Schneidereit J, Schupp N, Linden C, Merz C, Ebert R, Jakob F. PloS one. 2012;7(1):e29959. DOI 10.1371/journal.pone.0029959; PMID 22242193; PMCID PMC3252365.
Vitamin D/vitamin D receptor axis regulates DNA repair during oncogene-induced senescence.
Published in Graziano S, Johnston R, Deng O, Zhang J, Gonzalo S. Oncogene (2016).
Publication details
[2] Vitamin D/vitamin D receptor axis regulates DNA repair during oncogene-induced senescence. Graziano S, Johnston R, Deng O, Zhang J, Gonzalo S. Oncogene. 2016;35(41):5362-5376. DOI 10.1038/onc.2016.77; PMID 27041576; PMCID PMC5050051.
Vitamin D3 inhibits p38 MAPK and senescence‐associated inflammatory mediator secretion by senescent fibroblasts that impacts immune responses during ageing
Vitamin D3 replacement in older insufficient adults significantly improves their antigen‐specific varicella zoster virus (VZV) cutaneous immunity.
Publication details
[3] Vitamin D3 inhibits p38 MAPK and senescence-associated inflammatory mediator secretion by senescent fibroblasts that impacts immune responses during ageing. Sayegh S, Fantecelle CH, Laphanuwat P, Subramanian P, Rustin MHA, Gomes DCO, Akbar AN, Chambers ES. Aging cell. 2024;23(4):e14093. DOI 10.1111/acel.14093; PMID 38287646; PMCID PMC11019144.
Detrimental pro-senescence effects of vitamin D on lung fibrosis
The multiple biological effects of vitamin D and its novel activities on inflammation and redox homeostasis have raised high expectations on its use as a therapeutic agent for multiple fibrogenic conditions.
Publication details
[4] Detrimental pro-senescence effects of vitamin D on lung fibrosis. Guijarro T, Magro-Lopez E, Manso J, Garcia-Martinez R, Fernandez-Aceñero MJ, Liste I, Zambrano A. Molecular medicine (Cambridge, Mass.). 2018;24(1):64. DOI 10.1186/s10020-018-0064-z; PMID 30567504; PMCID PMC6299997.
Calcitriol induces cell senescence of kidney cancer through JMJD3 mediated histone demethylation.
Published in Shen Y, Yu D, Qi P, Wang X, Guo X, Zhang A. Oncotarget (2017).
Publication details
[5] Calcitriol induces cell senescence of kidney cancer through JMJD3 mediated histone demethylation. Shen Y, Yu D, Qi P, Wang X, Guo X, Zhang A. Oncotarget. 2017;8(59):100187-100195. DOI 10.18632/oncotarget.22124; PMID 29245970; PMCID PMC5725012.
A noncanonical cGAS-STING pathway drives cellular and organismal aging.
[6] A noncanonical cGAS-STING pathway drives cellular and organismal aging.
Publication details
[6] A noncanonical cGAS-STING pathway drives cellular and organismal aging. Cancado de Faria R, Silva LND, Teodoro-Castro B, McCommis KS, Shashkova EV, Gonzalo S. Proceedings of the National Academy of Sciences of the United States of America. 2025;122(28):e2424666122. DOI 10.1073/pnas.2424666122; PMID 40638086; PMCID PMC12280946.
Active vitamin D protects against osteoporosis by promoting VDR-dependent CDK2 transcription and P27 degradation.
Published in Xu F, Liu Q, Huang M, Wang J, Goltzman D, Gu B, Miao D. European journal of endocrinology (2026).
Publication details
[7] Active vitamin D protects against osteoporosis by promoting VDR-dependent CDK2 transcription and P27 degradation. Xu F, Liu Q, Huang M, Wang J, Goltzman D, Gu B, Miao D. European journal of endocrinology. 2026;195(2):329-344. DOI 10.1093/ejendo/lvag152; PMID 42592858.
Co-administration of vitamin D and N-acetylcysteine to modulate immunosenescence in older adults with vitamin D deficiency: a randomized clinical trial.
Published in Rastgoo S, Pourvali K, Raeissadat SA, Eslamian G, Zand H. Frontiers in immunology (2025).
Publication details
[8] Co-administration of vitamin D and N-acetylcysteine to modulate immunosenescence in older adults with vitamin D deficiency: a randomized clinical trial. Rastgoo S, Pourvali K, Raeissadat SA, Eslamian G, Zand H. Frontiers in immunology. 2025;16:1570441. DOI 10.3389/fimmu.2025.1570441; PMID 40421021; PMCID PMC12104082.
Corrigendum: Co-administration of vitamin D and N-acetylcysteine to modulate immunosenescence in older adults with vitamin D deficiency: a randomized clinical trial
Published in Rastgoo S, Pourvali K, Raeissadat SA, Eslamian G, Zand H. Frontiers in Immunology (2025).
Publication details
[9] Corrigendum: Co-administration of vitamin D and N-acetylcysteine to modulate immunosenescence in older adults with vitamin D deficiency: a randomized clinical trial Rastgoo S, Pourvali K, Raeissadat SA, Eslamian G, Zand H. Frontiers in Immunology. 2025;16:1627178. DOI 10.3389/fimmu.2025.1627178; PMID 40510343.